Faccio R - Search Results

1

Antagonizing Integrin β3 Increases Immunosuppression in Cancer.

Su X, Esser AK, Amend SR, Xiang J, Xu Y, Ross MH, Fox GC, Kobayashi T, Steri V, Roomp K, Fontana F, Hurchla MA, Knolhoff BL, Meyer MA, Morgan EA, Tomasson JC, Novack JS, Zou W, Faccio R, Novack DV, Robinson SD, Teitelbaum SL, DeNardo DG, Schneider JG, Weilbaecher KN. Su X, et al. Among authors: faccio r. Cancer Res. 2016 Jun 15;76(12):3484-95. doi: 10.1158/0008-5472.CAN-15-2663. Epub 2016 May 23. Cancer Res. 2016. PMID: 27216180 Free PMC article.

2

A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function.

Feng X, Novack DV, Faccio R, Ory DS, Aya K, Boyer MI, McHugh KP, Ross FP, Teitelbaum SL. Feng X, et al. Among authors: faccio r. J Clin Invest. 2001 May;107(9):1137-44. doi: 10.1172/JCI12040. J Clin Invest. 2001. PMID: 11342577 Free PMC article.

3

c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation.

Faccio R, Takeshita S, Zallone A, Ross FP, Teitelbaum SL. Faccio R, et al. J Clin Invest. 2003 Mar;111(5):749-58. doi: 10.1172/JCI16924. J Clin Invest. 2003. PMID: 12618529 Free PMC article.

4

Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin.

Faccio R, Novack DV, Zallone A, Ross FP, Teitelbaum SL. Faccio R, et al. J Cell Biol. 2003 Aug 4;162(3):499-509. doi: 10.1083/jcb.200212082. J Cell Biol. 2003. PMID: 12900398 Free PMC article.

5

High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype.

Faccio R, Zou W, Colaianni G, Teitelbaum SL, Ross FP. Faccio R, et al. J Cell Biochem. 2003 Dec 1;90(5):871-83. doi: 10.1002/jcb.10694. J Cell Biochem. 2003. PMID: 14624447

6

The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling.

Wang MW, Wei S, Faccio R, Takeshita S, Tebas P, Powderly WG, Teitelbaum SL, Ross FP. Wang MW, et al. Among authors: faccio r. J Clin Invest. 2004 Jul;114(2):206-13. doi: 10.1172/JCI15797. J Clin Invest. 2004. PMID: 15254587 Free PMC article.

7

Vav3 regulates osteoclast function and bone mass.

Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, Tybulewicz VL, Ross FP, Swat W. Faccio R, et al. Nat Med. 2005 Mar;11(3):284-90. doi: 10.1038/nm1194. Epub 2005 Feb 13. Nat Med. 2005. PMID: 15711558

8

PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.

Mao D, Epple H, Uthgenannt B, Novack DV, Faccio R. Mao D, et al. Among authors: faccio r. J Clin Invest. 2006 Nov;116(11):2869-79. doi: 10.1172/JCI28775. Epub 2006 Oct 19. J Clin Invest. 2006. PMID: 17053833 Free PMC article.

9

The LIM protein, Limd1, regulates AP-1 activation through an interaction with Traf6 to influence osteoclast development.

Feng Y, Zhao H, Luderer HF, Epple H, Faccio R, Ross FP, Teitelbaum SL, Longmore GD. Feng Y, et al. Among authors: faccio r. J Biol Chem. 2007 Jan 5;282(1):39-48. doi: 10.1074/jbc.M607399200. Epub 2006 Nov 8. J Biol Chem. 2007. PMID: 17092936 Free article.

10

Jawing about TNF: new hope for cherubism.

Novack DV, Faccio R. Novack DV, et al. Among authors: faccio r. Cell. 2007 Jan 12;128(1):15-7. doi: 10.1016/j.cell.2006.12.019. Cell. 2007. PMID: 17218248 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page